Abstract
Multidrug resistance (MDR) is a serious complication during treatment of opportunistic fungal infections that frequently afflict immunocompromised individuals, such as transplant recipients and cancer patients undergoing cytotoxic chemotherapy. Improved knowledge of the molecular pathways controlling MDR in pathogenic fungi should facilitate the development of novel therapies to combat these intransigent infections. MDR is often caused by upregulation of drug efflux pumps by members of the fungal zinc-cluster transcription-factor family (for example Pdr1p orthologues). However, the molecular mechanisms are poorly understood. Here we show that Pdr1p family members in Saccharomyces cerevisiae and the human pathogen Candida glabrata directly bind to structurally diverse drugs and xenobiotics, resulting in stimulated expression of drug efflux pumps and induction of MDR. Notably, this is mechanistically similar to regulation of MDR in vertebrates by the PXR nuclear receptor, revealing an unexpected functional analogy of fungal and metazoan regulators of MDR. We have also uncovered a critical and specific role of the Gal11p/MED15 subunit of the Mediator co-activator and its activator-targeted KIX domain in antifungal/xenobiotic-dependent regulation of MDR. This detailed mechanistic understanding of a fungal nuclear receptor-like gene regulatory pathway provides novel therapeutic targets for the treatment of multidrug-resistant fungal infections.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evolutionary and reverse engineering in Saccharomyces cerevisiae reveals a Pdr1p mutation-dependent mechanism for 2-phenylethanol tolerance
Microbial Cell Factories Open Access 23 December 2022
-
SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes
Nature Communications Open Access 12 April 2022
-
RPD3 and UME6 are involved in the activation of PDR5 transcription and pleiotropic drug resistance in ρ0 cells of Saccharomyces cerevisiae
BMC Microbiology Open Access 09 November 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Richardson, M. D. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56, i5–i11 (2005)
Aperis, G., Myriounis, N., Spanakis, E. K. & Mylonakis, E. Developments in the treatment of candidiasis: more choices and new challenges. Expert Opin. Investig. Drugs 15, 1319–1336 (2006)
Pfaller, M. A. & Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133–163 (2007)
Wisplinghoff, H. et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309–317 (2004)
Klepser, M. E. Candida resistance and its clinical relevance. Pharmacotherapy 26, 68S–75S (2006)
Sipos, G. & Kuchler, K. Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification. Curr. Drug Targets 7, 471–481 (2006)
Balzi, E. et al. The multidrug resistance gene PDR1 from Saccharomyces cerevisiae . J. Biol. Chem. 262, 16871–16879 (1987)
Meyers, S. et al. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr. Genet. 21, 431–436 (1992)
Balzi, E. et al. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269, 2206–2214 (1994)
Katzmann, D. J. et al. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol. Cell. Biol. 14, 4653–4661 (1994)
Delaveau, T. et al. PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol. Gen. Genet. 244, 501–511 (1994)
Decottignies, A. et al. Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J. Biol. Chem. 270, 18150–18157 (1995)
Katzmann, D. J. et al. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae . Mol. Cell. Biol. 15, 6875–6883 (1995)
van den Hazel, H. B. et al. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J. Biol. Chem. 274, 1934–1941 (1999)
Moye-Rowley, W. S. Transcriptional control of multidrug resistance in the yeast Saccharomyces . Prog. Nucleic Acid Res. Mol. Biol. 73, 251–279 (2003)
Mamnun, Y. M., Schuller, C. & Kuchler, K. Expression regulation of the yeast PDR5 ATP-binding cassette (ABC) transporter suggests a role in cellular detoxification during the exponential growth phase. FEBS Lett. 559, 111–117 (2004)
Gao, C., Wang, L., Milgrom, E. & Shen, W. C. On the mechanism of constitutive Pdr1 activator-mediated PDR5 transcription in Saccharomyces cerevisiae: evidence for enhanced recruitment of coactivators and altered nucleosome structures. J. Biol. Chem. 279, 42677–42686 (2004)
Lucau-Danila, A. et al. Early expression of yeast genes affected by chemical stress. Mol. Cell. Biol. 25, 1860–1868 (2005)
Alenquer, M., Tenreiro, S. & Sa-Correia, I. Adaptive response to the antimalarial drug artesunate in yeast involves Pdr1p/Pdr3p-mediated transcriptional activation of the resistance determinants TPO1 and PDR5. FEMS Yeast Res. 6, 1130–1139 (2006)
Fardeau, V. et al. The central role of PDR1 in the foundation of yeast drug resistance. J. Biol. Chem. 282, 5063–5074 (2007)
Vermitsky, J. P. & Edlind, T. D. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 48, 3773–3781 (2004)
Tsai, H. F., Krol, A. A., Sarti, K. E. & Bennett, J. E. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob. Agents Chemother. 50, 1384–1392 (2006)
Vermitsky, J. P. et al. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol. Microbiol. 61, 704–722 (2006)
Kliewer, S. A., Goodwin, B. & Willson, T. M. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23, 687–702 (2002)
Willson, T. M. & Kliewer, S. A. PXR, CAR and drug metabolism. Nature Rev. Drug Discov. 1, 259–266 (2002)
Näär, A. M., Lemon, B. D. & Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70, 475–501 (2001)
Kornberg, R. D. Mediator and the mechanism of transcriptional activation. Trends Biochem. Sci. 30, 235–239 (2005)
Kean, L. S. et al. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3. J. Cell Biol. 138, 255–270 (1997)
Gulshan, K., Rovinsky, S. A., Coleman, S. T. & Moye-Rowley, W. S. Oxidant-specific folding of Yap1p regulates both transcriptional activation and nuclear localization. J. Biol. Chem. 280, 40524–40533 (2005)
Novatchkova, M. & Eisenhaber, F. Linking transcriptional mediators via the GACKIX domain super family. Curr. Biol. 14, R54–R55 (2004)
Yang, F. et al. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442, 700–704 (2006)
Goodman, R. H. & Smolik, S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553–1577 (2000)
Kasper, L. H. et al. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 419, 738–743 (2002)
Kasper, L. H. et al. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell. Biol. 26, 789–809 (2006)
Radhakrishnan, I. et al. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91, 741–752 (1997)
Näär, A. M. et al. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev. 12, 3020–3031 (1998)
Dai, P. et al. CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10, 528–540 (1996)
Zor, T., De Guzman, R. N., Dyson, H. J. & Wright, P. E. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J. Mol. Biol. 337, 521–534 (2004)
De Guzman, R. N., Goto, N. K., Dyson, H. J. & Wright, P. E. Structural basis for cooperative transcription factor binding to the CBP coactivator. J. Mol. Biol. 355, 1005–1013 (2006)
Goto, N. K. et al. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J. Biol. Chem. 277, 43168–43174 (2002)
Parker, D. et al. Analysis of an activator:coactivator complex reveals an essential role for secondary structure in transcriptional activation. Mol. Cell 2, 353–359 (1998)
Parker, D. et al. Role of secondary structure in discrimination between constitutive and inducible activators. Mol. Cell. Biol. 19, 5601–5607 (1999)
Radhakrishnan, I. et al. Structural analyses of CREB–CBP transcriptional activator–coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. J. Mol. Biol. 287, 859–865 (1999)
Prasad, R., Gaur, N. A., Gaur, M. & Komath, S. S. Efflux pumps in drug resistance of Candida . Infect. Disord. Drug Targets 6, 69–83 (2006)
Pfaller, M. A. et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol. 45, 1735–1745 (2007)
Breger, J. et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathogens 3, e18 (2007)
Mylonakis, E. & Aballay, A. Worms and flies as genetically tractable animal models to study host–pathogen interactions. Infect. Immun. 73, 3833–3841 (2005)
Bertrand, S. et al. Evolutionary genomics of nuclear receptors: from twenty-five ancestral genes to derived endocrine systems. Mol. Biol. Evol. 21, 1923–1937 (2004)
Phelps, C. et al. Fungi and animals may share a common ancestor to nuclear receptors. Proc. Natl Acad. Sci. USA 103, 7077–7081 (2006)
Taubert, S., Van Gilst, M. R., Hansen, M. & Yamamoto, K. R. A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans . Genes Dev. 20, 1137–1149 (2006)
Sherman, F., Fink, G. R. & Hicks, J. B. Methods in Yeast Genetics (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1986)
Gietz, D., St Jean, A., Woods, R. A. & Schiestl, R. H. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20, 1425 (1992)
Cormack, B. P. & Falkow, S. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata . Genetics 151, 979–987 (1999)
Aparicio, J. G., Viggiani, C. J., Gibson, D. G. & Aparicio, O. M. The Rpd3-Sin3 histone deacetylase regulates replication timing and enables intra-S origin control in Saccharomyces cerevisiae . Mol. Cell. Biol. 24, 4769–4780 (2004)
Kepinski, S. & Leyser, O. The Arabidopsis F-box protein TIR1 is an auxin receptor. Nature 435, 446–451 (2005)
Breger, J. et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathogens 3, e18 (2007)
Ferentz, A. E. & Wagner, G. NMR spectroscopy: a multifaceted approach to macromolecular structure. Q. Rev. Biophys. 33, 29–65 (2000)
Frueh, D. P., Arthanari, H. & Wagner, G. Unambiguous assignment of NMR protein backbone signals with a time-shared triple-resonance experiment. J. Biomol. NMR 33, 187–196 (2005)
Takahashi, H. et al. A novel NMR method for determining the interfaces of large protein–protein complexes. Nature Struct. Mol. Biol. 7, 220–223 (2000)
Guntert, P., Mumenthaler, C. & Wuthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273, 283–298 (1997)
Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289–302 (1999)
Acknowledgements
We thank C. Wivagg and M. Franzmann for their help with the NMR assignment and fluorescence studies; and N. Dyson, S. Buratowski, A. Walker and H. Najafi-Shoushtari for comments on the manuscript. We were unable to cite many original papers owing to space constraints. This work was supported by grants from the National Institutes of Health: GM071449 (A.M.N.), CA127990 (G.W./A.M.N.), A1046223 (B.P.C.), GM49825 (W.S.M.-R.) and GM30186 (K.S.). The NMR facility used for this research was supported by grants GM47467 and EB2026. J.K.T. was supported by a fellowship from the MGH Fund for Medical Discovery.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
The file contains Supplementary Figures 1-11 with Legends and Supplementary Tables 1-3 The Supplementary Figures describe data in support of the main findings presented in the print version of the paper. The Supplementary Table 1 shows the fungal strains used in the paper, the Supplementary Table 2 lists the primers used for quantitative real-time RT-PCR, and the Supplementary Table 3 outlines the structural NMR data and parameters. (PDF 2504 kb)
Rights and permissions
About this article
Cite this article
Thakur, J., Arthanari, H., Yang, F. et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452, 604–609 (2008). https://doi.org/10.1038/nature06836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature06836
This article is cited by
-
Evolutionary and reverse engineering in Saccharomyces cerevisiae reveals a Pdr1p mutation-dependent mechanism for 2-phenylethanol tolerance
Microbial Cell Factories (2022)
-
SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes
Nature Communications (2022)
-
RPD3 and UME6 are involved in the activation of PDR5 transcription and pleiotropic drug resistance in ρ0 cells of Saccharomyces cerevisiae
BMC Microbiology (2021)
-
Assessing regulatory features of the current transcriptional network of Saccharomyces cerevisiae
Scientific Reports (2020)
-
Protonophore FCCP provides fitness advantage to PDR-deficient yeast cells
Journal of Bioenergetics and Biomembranes (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.